In Depth: What’s Next for China’s Covid Vaccine Strategy?

In September, China approved two Covid-19 vaccines for emergency use as heterologous boosters — vaccines that are different from the ones people use to complete their primary series of inoculations. Photo: VCG

China’s announcement to “optimize” its Covid strategy on Nov. 11 gave markets reasons to cheer and even led economics professor Liang Jianzhang to predict in a Caixin opinion piece that authorities would consider a full return to its pre-pandemic state.

The latest Covid response put forward 20 new guidelines including ending the “circuit breaker” mechanism for inbound flights and shortening the quarantine period for overseas travelers.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS